Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Dare Bioscience Q2 2024 GAAP EPS $1.52, Sales $22.438M

Author: Benzinga Newsdesk | August 12, 2024 04:31pm

Dare Bioscience (NASDAQ:DARE) reported quarterly earnings of $1.52 per share. The company reported $22.438 million in sales this quarter.

Posted In: DARE